⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12811510 | 0.88 | FDPS (0.38) | — | |
| SCHEMBL3086212 | 0.82 | IDO1 (0.41) | — | |
| SCHEMBL14722200 | 0.81 | THRB (0.39) | — | |
| SCHEMBL29746497 | 0.79 | — | — | |
| SCHEMBL31010062 | 0.79 | IDO1 (0.38) | — | |
| SCHEMBL31010140 | 0.79 | — | — | |
| SCHEMBL20282695 | 0.78 | — | — | |
| SCHEMBL14466608 | 0.78 | — | — | |
| SCHEMBL5713341 | 0.78 | DAO (0.50) | — | |
| SCHEMBL15465485 | 0.78 | FDPS (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174679-A1 | HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2024-05-30 | — | — | US | claimed |
| EP-3672952-B1 | BENZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2022-12-14 | — | — | EP | claimed |
| EP-3661941-B1 | THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2022-12-14 | — | — | EP | claimed |
| US-20220372040-A1 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC. (US) | 2022-11-24 | — | — | US | claimed |
| CN-115279756-A | METTL3 modulators | 埃克森特治疗公司 | 2022-11-01 | — | — | CN | claimed |
| EP-4048670-A1 | METTL3 MODULATORS | Accent Therapeutics, Inc. (US) | 2022-08-31 | — | — | EP | claimed |
| WO-2021081211-A1 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC. (US) | 2021-04-29 | — | — | WO | claimed |
| EP-4727934-A1 | TREM2 AGONISTS | F. Hoffmann-La Roche AG (CH) | 2026-04-22 | — | — | EP | disclosed |
| US-12600728-B2 | Interleukin-17 inhibitors | NOVARTIS AG (CH) | 2026-04-14 | — | — | US | disclosed |
| EP-4673111-A1 | COLORANT COMPOSITION FOR DYEING KERATIN FIBERS AND DYE KIT CONTAINING THE SAME | L'OREAL (FR) | 2026-01-07 | — | — | EP | disclosed |
| WO-2025264954-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4646410-A1 | TUBULIN POLYMERIZATION INHIBITORS | AB Science (FR) | 2025-11-12 | — | — | EP | disclosed |
| US-20250270190-A1 | KIT INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2025-08-28 | — | — | US | disclosed |
| WO-2000066567-A1 | PYRIMIDINONE COMPOUNDS | SMITHKLINE BEECHAM PLC (GB) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000058373-A1 | PROCESS FOR PRODUCING POLYOLEFINS | EASTMAN CHEMICAL COMPANY (US) | 2000-10-05 | — | — | WO | disclosed |
| WO-2000058372-A1 | PROCESS FOR PRODUCING POLYOLEFINS | EASTMAN CHEMICAL COMPANY (US) | 2000-10-05 | — | — | WO | disclosed |
| WO-2000058371-A1 | PROCESS FOR PRODUCING POLYOLEFINS | EASTMAN CHEMICAL COMPANY (US) | 2000-10-05 | — | — | WO | disclosed |
| WO-2000052069-A1 | PROCESS FOR PRODUCING POLYETHYLENE | EASTMAN CHEMICAL COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000052068-A1 | PROCESS FOR PRODUCING POLYETHYLENE | EASTMAN CHEMICAL COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000052067-A1 | PROCESS FOR PRODUCING POLYETHYLENE | EASTMAN CHEMICAL COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |